Voices
Miguel Gonzalez Velez: Association Between CEA Reduction and Survival Outcomes in Advanced NSCLC
Miguel Gonzalez Velez/X

Miguel Gonzalez Velez: Association Between CEA Reduction and Survival Outcomes in Advanced NSCLC

Miguel Gonzalez Velez, Medical Oncologist at John Theurer Cancer Center, Hackensack University Medical Center, shared a post on X:

“Anyone in the US regularly uses CEA as indirect response marker or ctDNA beat nonspecific markers.

Study from Latin America.”

Miguel Gonzalez Velez: Association Between CEA Reduction and Survival Outcomes in Advanced NSCLC

Title: Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer

Authors: Oscar Arrieta, Edgar Varela-Santoyo, Andrés F. Cardona, Roberto Sánchez-Reyes, Luis Lara-Mejía, Suraj Samtani Bassarmal, Dafne Valle-Bautista, Luis Corrales-Rodríguez, Daniel Motola-Kuba, Luis Cabrera-Miranda, Claudio Martín

Read the full article.

Miguel Gonzalez Velez: Association Between CEA Reduction and Survival Outcomes in Advanced NSCLC

Other articles about NSCLC on OncoDaily.

Andres F. Cardona cancer CEA Claudio Martin ctDNA Dafne Valle-Bautista Daniel Motola-Kuba Edgar Varela-Santoyo Luis Cabrera-Miranda Luis Corrales-Rodríguez Luis Lara-Mejía Miguel Gonzalez Velez NSCLC OncoDaily Oncology Oscar Arrieta Roberto Sánchez-Reyes Suraj Samtani Bassarmal